Quercetin: An Over-The-Counter Hydroxychloroquine, or Something More?

Part IV: Citations

Although all of the studies I used are linked throughout the newsletters, here’s a collection for anyone who wants to look at the studies themselves. It’s important to note that I may have misinterpreted a study or missed important information, so for those who are interested in fact checking and examining the studies themselves you can do so!

Citations

1. Mlcek et. al. 2016. Quercetin and Its Anti-Allergic Immune Response. Taken from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273625/

2. Biancatelli et. al. 2020. Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19). Taken from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318306/

3. Xu et. al. 2019. Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application. Taken from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470739/

4. Yao et. al. 2018. Inhibition of enterovirus 71 replication and viral 3C protease by quercetin. Taken from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069798/

5. Li et. al. 2020. Inhibition of Porcine Epidemic Diarrhea Virus Replication and Viral 3C-Like Protease by Quercetin. Taken from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662296/

6. Dabbagh-Bazarbachi et. al. 2014. Zinc ionophore activity of quercetin and epigallocatechin-gallate: from Hepa 1-6 cells to a liposome model. Taken from https://pubmed.ncbi.nlm.nih.gov/25050823/

7. Smith et. al. 2020. Repurposing Therapeutics for COVID-19: Supercomputer-Based Docking to the SARS-COV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 Interface. Taken from https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/60c74980f96a00352b28727c/original/repurposing-therapeutics-for-covid-19-supercomputer-based-docking-to-the-sars-co-v-2-viral-spike-protein-and-viral-spike-protein-human-ace2-interface.pdf

8. Liu et. al. 2020. Quercetin and Its Metabolites Inhibit Recombinant Human Angiotensin-Converting Enzyme 2 (ACE2) Activity. Taken from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687294/

9. Tao et. al. 2020. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19. Taken from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441778/

10. Albian et. al. 2020. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening. Taken from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395220/

11. Verma et. al. 2021. Factual insights of the allosteric inhibition mechanism of SARS-CoV-2 main protease by quercetin: an in silico analysis. Taken from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802979/

12. Li et. al. 2016. Quercetin, Inflammation and Immunity. Taken from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808895/

13. Heinz et. al. 2010. Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial. Taken from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128946/

14. Somerville et. al. 2016. Effect of Flavonoids on Upper Respiratory Tract Infections and Immune Function: A Systematic Review and Meta-Analysis1,2. Taken from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863266/

15. Margolin et. al. 2021. 20-Week Study of Clinical Outcomes of Over-the-Counter COVID-19 Prophylaxis and Treatment. Taken from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264737/

16. Pierro et. al. 2021. Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study. Taken from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197660/

17. Kim et. al. 2021. Plant-based diets, pescatarian diets and COVID-19 severity: a population-based case–control study in six countries. Taken from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219480/